首页 | 本学科首页   官方微博 | 高级检索  
     


Inhibition of prostaglandin synthesis by zidometacin
Affiliation:1. Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON, N6A 5B9, Canada;2. Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada;3. Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada;1. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA;3. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA;4. Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA;5. Laboratory of Systems Pharmacology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115, USA;6. Calico Life Sciences, South San Francisco, CA 94080, USA;7. Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, MA;1. Department of Medical Oncology;2. Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, USA;3. Broad Institute of MIT and Harvard, Cambridge, USA;4. Harvard Medical School, Boston, USA;5. Department of Medicine, Brigham and Women''s Hospital, Boston, USA;1. Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA;2. Next Generation Medicine Lab, Department of Artificial Intelligence & Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea;3. Department of Digital Health & Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Samsung Medical Center, Sungkyunkwan University, Seoul 06351, Republic of Korea;4. Pangea Therapeutics, Ltd., Tel Aviv 6971003, Israel;5. Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, Los Angeles, CA 90095, USA;6. Research and Innovations Group, Datar Cancer Genetics Limited, Nasik, Maharashtra 422010, India;7. Worldwide Innovative Network (WIN) Association-WIN Consortium, Villejuif 94801, France;8. The Center for Evolutionary Genomics and Medicine, Ben-Gurion University of the Negev, Beersheva 8410501, Israel;9. Department of Pathology, CHA University, CHA Bundang Medical Center, Seongnam 13497, Republic of Korea;10. Cancer Center, Chaim Sheba Medical Center, Tel Hashomer 5262000, Israel;11. Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA;12. Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA;13. Moore Cancer Center, University of California, San Diego, San Diego, CA 92037, USA;14. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea;15. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA;1. Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain;2. SOLTI Breast Cancer Research Group, Barcelona, Spain;3. Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain;4. Department of Medicine, University of Barcelona, Barcelona, Spain;5. Institute of Oncology (IOB)-Quirón, Barcelona, Spain
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号